Reflux Disease
7
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Development of a Preparation for Supportive Supplementation of Probiotics in Patients With Reflux
Deprescribing Inappropriate Proton Pump Inhibitors
Endoscopic Radiofrequency Ablation Versus Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features
Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population
AZD3355 Dose-escalation Study in Healthy Males